You are here: Industry Insights > European

News List

Emmaus Granted European Patent for L-glutamine to Treat Diverticulosis americanpharmaceuticalreview
September 04, 2019
Emmaus Life Sciences has announced the allowance of patent application number 12860587.0, directed to the treatment of diverticulosis, by the European Patent Office.
Imbruvica® granted expanded use from European Commission europeanpharmaceuticalreview
August 15, 2019
The European Commission has approved the drug for two indications: chronic lymphocytic leukaemia and Waldenström’s macroglobulinemia.
European Medicines Agency Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for Review b3cnewswire
May 29, 2019
European Medicines Agency Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for Review.
Intec Pharma Granted European Patent americanpharmaceuticalreview
May 22, 2019
Intec Pharma has announced the European Patent Office has granted the Company European Patent No. 2997953 titled, "DELIVERY DEVICE FOR ORAL INTAKE OF AN AGENT," and ...
Sandoz to commercialise Shionogi’s Rizmoic in European markets pharmaceutical-technology
April 23, 2019
Sandoz to commercialise Shionogi’s Rizmoic in European markets...
Sandoz to commercialise Shionogi’s Rizmoic in European markets pharmaceutical-technology
April 23, 2019
Sandoz to commercialise Shionogi’s Rizmoic in European markets...
Aimovig approved by EU for migraine prevention europeanpharmaceuticalreview
April 19, 2019
Researchers found that more than one quarter (26 per cent) of patients taking Aimovig 70mg were migraine free after month 15…
Pharma firms step up plans to beat Brexit supply chain disruption europeanpharmaceuticalreview
April 19, 2019
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39…
Greenfield Global Plans for New European Mfg. HQ contractpharma
April 19, 2019
Greenfield Global Inc has announced plans to establish a new EU manufacturing headquarters in Portlaoise, Ireland.
Implandata Successfully Gains CE Mark for Next-Generation EyeMate System and Poised for European-Wide Market Launch b3cnewswire
April 17, 2019
Implandata Successfully Gains CE Mark for Next-Generation EyeMate System and Poised for European-Wide Market Launch.

Previous page 1 2 3 Next page